NCT03312543

Brief Summary

This research study will test how well a light therapy mask works for women with mild to moderate hyperpigmentation (brown spots) and moderate to severe facial wrinkles, as compared to a "sham" or inactive investigational light therapy mask. The study will also test if the light therapy mask causes any irritation. For the first 12 weeks of the study, participants will use the assigned mask, along with a provided cleanser and sunscreen. For the second 12 weeks of the study, participants will use just the cleanser and sunscreen.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

October 9, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 17, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 6, 2018

Completed
11 months until next milestone

Results Posted

Study results publicly available

March 5, 2019

Completed
Last Updated

March 5, 2019

Status Verified

February 1, 2019

Enrollment Period

3 months

First QC Date

October 6, 2017

Results QC Date

January 4, 2019

Last Update Submit

March 4, 2019

Conditions

Keywords

Photoaging of Skin, Skin Wrinkling, Solar Aging of Skin, light therapy

Outcome Measures

Primary Outcomes (4)

  • Global Wrinkling - Change From Baseline to Week 12, Averaged Expert Grader Scores

    3 Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. The 3 Expert Grader scores were averaged for Baseline and for Week 12. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement.

    Baseline to Week 12

  • Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 1

    Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 1 were calculated individually.

    Baseline to Week 12

  • Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 2

    Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 2 were calculated individually.

    Baseline to Week 12

  • Global Wrinkling - Change From Baseline to Week 12, Individual Expert Grader Scores - Expert Grader 3

    Each Expert Graders evaluated global wrinkling on a 1-9 scale, where 1 = mildest wrinkles to 9 = most severe wrinkles. Change from baseline was calculated as Baseline mean minus Week 12 mean so a positive score indicates improvement. Scores for Expert Grader 3 were calculated individually.

    Baseline to Week 12

Secondary Outcomes (31)

  • Global Wrinkling - Change From Baseline to Week 1

    Baseline to Week 1

  • Global Wrinkling - Change From Baseline to Week 4

    Baseline to Week 4

  • Global Wrinkling - Change From Baseline to Week 24

    Baseline to Week 24

  • Fine Lines - Change From Baseline to Week 1

    1 week

  • Fine Lines - Change From Baseline to Week 4

    Baseline to Week 4

  • +26 more secondary outcomes

Study Arms (2)

Active Cell: Active Mask

EXPERIMENTAL

Cleanser, Moisturizer, Active Mask

Device: Active Mask

Sham Cell: Sham Mask

SHAM COMPARATOR

Cleanser, Moisturizer, Sham Mask

Device: Sham Mask

Interventions

A facial cleanser will be used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF will be applied full-face. For the first 12 weeks of the study, the active light therapy mask will be used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage will be discontinued.

Also known as: Active Light Therapy Mask
Active Cell: Active Mask
Sham MaskDEVICE

A facial cleanser will be used twice daily (morning and evening). In the morning after washing, the moisturizer with SPF will be applied full-face. For the first 12 weeks of the study, the sham light therapy mask will be used for 10 minutes in the evening after washing/drying the face. For the second 12 weeks of the study, mask usage will be discontinued.

Also known as: Sham Light Therapy Mask
Sham Cell: Sham Mask

Eligibility Criteria

Age35 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has mild to moderate brown spots
  • Has moderate to severe facial wrinkling
  • Able to read, write, speak, and understand English
  • In general good health
  • If capable of having a child: must agree to practice a medically acceptable form of birth control.
  • Intends to complete the study and willing to follow all study directions.

You may not qualify if:

  • Allergies/sensitivity to skincare products or the test product ingredients
  • Has a light or photosensitivity disorder or another medical condition that could increase risk to the subject or confuse the study results.
  • Is taking medication that may cause skin sensitivity to light
  • Has been using a product or medication that the study investigator determines will increase health risk to the subject or confuse the study results
  • Has a facial skin condition (e.g. rosacea, acne, eczema, etc.) that could increase health risk to the subject or confuse the study results.
  • Has skin cancer or a history of skin cancer.
  • Has an immune deficiency disorder, active hepatitis, or an autoimmune disease.
  • Has an uncontrolled metabolic condition (e.g. diabetes, hypertension)
  • Is pregnant, nursing, or planning to become pregnant.
  • Plans to start or change a hormone replacement therapy during the study.
  • Has participated in another study in the past 30 days or plans to during the study.
  • Is an employee or relative of the Study Site, Investigator, or Sponsor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KGL Skin Study Center, LLC

Broomall, Pennsylvania, 19008, United States

Location

Related Publications (6)

  • Fitzpatrick RE. Laser resurfacing of rhytides. Dermatol Clin. 1997 Jul;15(3):431-47. doi: 10.1016/s0733-8635(05)70452-6.

    PMID: 9189680BACKGROUND
  • McCullough JL, Kelly KM. Prevention and treatment of skin aging. Ann N Y Acad Sci. 2006 May;1067:323-31. doi: 10.1196/annals.1354.044.

    PMID: 16804006BACKGROUND
  • Weiss RA, McDaniel DH, Geronemus RG. Review of nonablative photorejuvenation: reversal of the aging effects of the sun and environmental damage using laser and light sources. Semin Cutan Med Surg. 2003 Jun;22(2):93-106. doi: 10.1053/sder.2003.50008.

    PMID: 12877228BACKGROUND
  • Kim JW. Clinical trial of nonthermal 633 nm Omnilux LED array for renewal of photoaging: clinical surface profile metric results. Korea Soc Las Med Surg. 2005; 9:69-76.

    BACKGROUND
  • Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch Dermatol. 1996 Apr;132(4):395-402.

    PMID: 8629842BACKGROUND
  • Griffiths CE, Wang TS, Hamilton TA, Voorhees JJ, Ellis CN. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol. 1992 Mar;128(3):347-51.

    PMID: 1550366BACKGROUND

Results Point of Contact

Title
Sidney Hornby
Organization
Johnson & Johnson Consumer Inc.

Study Officials

  • Stuart Lessin, M.D.

    KGL Skin Study Center, LLC

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2017

First Posted

October 17, 2017

Study Start

October 9, 2017

Primary Completion

January 12, 2018

Study Completion

April 6, 2018

Last Updated

March 5, 2019

Results First Posted

March 5, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations